THB Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History

THB Asset Management’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$979K	Sell	33,745 -14,640	-30%	-$419K	0.22%	116
2020 Q3	$1.36M	Sell	48,385 -3,117	-6%	-$92.8K	0.38%	87
2020 Q2	$1.67M	Sell	51,502 -1,462	-3%	-$52.4K	0.48%	76
2020 Q1	$2.16M	Sell	52,964 -38,054	-42%	-$2.02M	0.68%	61
2019 Q4	$5.61M	Buy	91,018 +3,916	+4%	+$259K	1.04%	39
2019 Q3	$6.35M	Sell	87,102 -2,203	-2%	-$165K	1.17%	30
2019 Q2	$7.34M	Buy	89,305 +63,874	+251%	+$4.54M	1.17%	32
2019 Q1	$1.79M	Buy	25,431 +275	+1%	+$16.2K	0.26%	98
2018 Q4	$1.13M	Hold	25,156	–	–	0.17%	102
2018 Q3	$1.42M	Buy	25,156 +1,258	+5%	+$77K	0.17%	102
2018 Q2	$1.6M	Buy	23,898 +1,705	+8%	+$106K	0.19%	102
2018 Q1	$1.29M	Buy	22,193 +2,092	+10%	+$133K	0.17%	106
2017 Q4	$1.29M	Buy	20,101 +5,006	+33%	+$311K	0.17%	105
2017 Q3	$792K	Buy	15,095 +1,590	+12%	+$75.8K	0.11%	122
2017 Q2	$632K	Buy	13,505 +4,582	+51%	+$221K	0.08%	138
2017 Q1	$441K	Hold	8,923	–	–	0.06%	167
2016 Q4	$540K	Hold	8,923	–	–	0.07%	161
2016 Q3	$592K	Sell	8,923 -939	-10%	-$58.7K	0.09%	144
2016 Q2	$550K	Buy	+9,862	New	+$479K	0.07%	155

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

ICOM

Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

THB Asset Management's ANIP Position: Q4 2020 in Review

THB Asset Management reduced its ANI Pharmaceuticals (ANIP) stake by 30% in Q4 2020, selling an estimated $419K and leaving 33,745 shares worth $979K. The position accounts for 0.22% of the portfolio, ranked #116.

THB Asset Management first reported a position in ANIP in Q2 2016 and has held it in 19 quarters since. The position peaked at $7.34M in Q2 2019. 117 funds tracked by Wall St. Rank hold ANIP as of Q4 2020.

THB Asset Management held 33,745 shares of ANI Pharmaceuticals worth $979K as of Q4 2020.
THB Asset Management sold 14,640 ANI Pharmaceuticals shares in Q4 2020, an estimated $419K.
ANI Pharmaceuticals made up 0.22% of THB Asset Management's portfolio in Q4 2020, its #116 holding.
THB Asset Management first reported a position in ANI Pharmaceuticals in Q2 2016 and has held it in 19 quarters since.
THB Asset Management's ANI Pharmaceuticals position peaked at $7.34M in Q2 2019.
117 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2020.

Based on THB Asset Management's 13F filing for Q4 2020, filed 5 Feb 2021.